@article{ACS17277,
author = {Arman Arghami and Behrooz Banivaheb and Hartzell V. Schaff},
title = {Impact of mitral annular calcification in mitral valve surgery: 25-year Mayo Clinic experience},
journal = {Annals of Cardiothoracic Surgery},
volume = {14},
number = {6},
year = {2025},
keywords = {},
abstract = {Background: Annular calcification [mitral annular calcification (MAC)] may complicate mitral valve (MV) surgery, and long‑term outcome data are limited.
Methods: We reviewed adult patients undergoing MV surgery at our Clinic between January 2000 and December 2024. MAC was identified on preoperative imaging, and operative strategy prioritized repair when feasible and employed conservative debridement when necessary. Patients with MAC were matched 1:1 with patients without MAC using a propensity score.
Results: Among 11,350 MV operations with or without concomitant procedures, 1,603 patients (14.1%) had MAC, the median age was 72.6 years [interquartile range (IQR), 65.3–78.6 years], 54.8% were female. In the MAC cohort, 21% of patients had a prior sternotomy. Concomitant aortic valve replacement (AVR) and coronary artery bypass grafting (CABG) were performed in 32% and 24% of cases, respectively. Compared with propensity-matched controls, MAC patients did not exhibit significantly prolonged cardiopulmonary bypass times (115 vs. 112 minutes, P=0.485) or aortic cross-clamp durations (86 vs. 81 minutes, P=0.273). The 30-day hospital readmission rate was significantly higher among MAC patients (15.9% vs. 9.9%, P},
issn = {2304-1021}, url = {https://www.annalscts.com/article/view/17277}
}